In this video, Paul M. Ridker, MD, MPH, discusses his team's recent study, which found that vascular inflammation levels in patients on statin therapy are better predictors of future cardiovascular events...
Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
Early adulthood hypertension or increased blood pressure is associated with negative brain changes later in life including lower regional brain volumes and worse white matter integrity, factors that are...
In this interview, Jacob C. Jentzer, MD, Assistant Professor of Medicine in the Department of Cardiovascular Medicine at the Mayo Clinic in Rochester, Minnesota discusses the implications of his study and...
In this video, Michael J. Bloch, MD, discusses the implications of a recently published study on the association of menstrual cycle regularity and length with cardiovascular diseases, including gaps in the...
In this episode, Seth Martin, MD, speaks with Francoise Marvel, MD, about innovative approaches to implementing prevention guidelines, including the future of digital health and cardiovascular care.
In this commentary, Michael J. Bloch, MD, writes about the epidemiological link between influenza infection and cardiovascular events and the potential benefits of influenza vaccination on cardiovascular...
In this commentary, Michael J. Bloch, MD writes about controversies in the effect of dietary cholesterol and egg consumption on cardiovascular events and mortality.
In this article, James Matera, DO, writes about a newer agent, finarenone, which is a nonsteroidal, selective mineralocorticoid receptor antagonist that can treat chronic kidney disease.
He talks about the prevalence of sudden cardiac arrest among younger athletes, how to risk stratify this population, and the controversy around using electrocardiogram imaging in standard care.
